US FDA limits industry employees from roles in its advisory committees
U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies regulated by the agency, such as pharmaceutical firms, from serving as official members on FDA’s advisory committees, where legally allowed.
The directive on Thursday is aimed at promoting “radical transparency” and mitigating perceived industry influence and conflicts of interest, Makary said.
Makary, in a post on social media platform X, said the FDA has a history of being influenced unduly by corporate interests.
